{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:47:22Z","timestamp":1785851242330,"version":"3.56.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":70,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI19\/00125, PI23\/01858"],"award-info":[{"award-number":["PI19\/00125, PI23\/01858"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["CNS2022-136169"],"award-info":[{"award-number":["CNS2022-136169"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031566","name":"Instituto de Investigaci\u00f3n Sanitaria y Biom\u00e9dica de Alicante","doi-asserted-by":"publisher","award":["2021-0406, 2022-0338,2024\/C\/6, 2025\/C.1\/5, 2025\/C.1\/16"],"award-info":[{"award-number":["2021-0406, 2022-0338,2024\/C\/6, 2025\/C.1\/5, 2025\/C.1\/16"]}],"id":[{"id":"10.13039\/100031566","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Transcriptional dysregulation is among the most prominent molecular alterations in Huntington\u2019s disease (HD). It is not confined to the brain but also extends to peripheral tissues and cells, enabling minimally invasive screening strategies to identify transcriptional surrogates of the health status in HD mutation carriers. Nonetheless, transcriptomics approaches have failed to identify consistent candidates from peripheral blood, probably due to the low impact of the HD mutation in the transcriptional profiles of circulating cells, which can be masked by the high cellular complexity of this biofluid. In this study, we applied for the first time single-cell RNA-seq to peripheral blood mononuclear cells (PBMCs) to determine which cells accumulate the most prominent gene expression changes, and therefore, represent potential sources of reliable biomarkers. We observed common transcriptional alterations across different blood cell subtypes, which were partially validated in published bulk transcriptomics datasets. To relate these gene expression patterns with disease progression in the absence of a large cohort of patients, we examined selected candidates in a phenotypically characterized cohort of transgenic R6\/1 mice. Among the tested genes, only the variations in the interferon related gene\n                    <jats:italic>Irf7<\/jats:italic>\n                    in blood were mildly correlated with motor coordination performance in mutant mice. Notably, striatal\n                    <jats:italic>Irf7<\/jats:italic>\n                    expression did not show such phenotypical correlation in the same individuals. Overall, transcriptional-based changes in peripheral blood can be linked to HD but they are mild and not apparently confined to particular cellular subpopulations. In conclusion, dissection of individual blood cells in combination with subsequent validation in mouse models emphasizes the challenges in obtaining clinically relevant biomarkers in HD.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-54412-4","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T07:13:11Z","timestamp":1779779591000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Single-cell transcriptomics and mouse model phenotyping for biomarker screen of peripheral blood in Huntington\u2019s disease"],"prefix":"10.1038","volume":"16","author":[{"given":"Paula","family":"Mart\u00edn-Climent","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samanta","family":"Ortu\u00f1o-Miquel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan F.","family":"Gallego-Serna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Mart\u00ed-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis M.","family":"Valor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"key":"54412_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23105411","author":"S Marti-Martinez","year":"2022","unstructured":"Marti-Martinez, S. & Valor, L. M. A glimpse of molecular biomarkers in Huntington\u2019s disease. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms23105411 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"54412_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.751033","volume":"12","author":"B Malla","year":"2021","unstructured":"Malla, B., Guo, X., Senger, G., Chasapopoulou, Z. & Yildirim, F. A systematic review of transcriptional dysregulation in Huntington\u2019s Disease studied by RNA sequencing. Front. Genet. 12, 751033. https:\/\/doi.org\/10.3389\/fgene.2021.751033 (2021).","journal-title":"Front. Genet."},{"key":"54412_CR3","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1007\/s12035-014-8715-8","volume":"51","author":"LM Valor","year":"2015","unstructured":"Valor, L. M. Transcription, epigenetics and ameliorative strategies in Huntington\u2019s Disease: A genome-wide perspective. Mol. Neurobiol. 51, 406\u2013423. https:\/\/doi.org\/10.1007\/s12035-014-8715-8 (2015).","journal-title":"Mol. Neurobiol."},{"key":"54412_CR4","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.nbd.2011.07.001","volume":"45","author":"T Seredenina","year":"2012","unstructured":"Seredenina, T. & Luthi-Carter, R. What have we learned from gene expression profiles in Huntington\u2019s Disease?. Neurobiol. Dis. 45, 83\u201398. https:\/\/doi.org\/10.1016\/j.nbd.2011.07.001 (2012).","journal-title":"Neurobiol. Dis."},{"key":"54412_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.573560","volume":"11","author":"MA Andrade-Navarro","year":"2020","unstructured":"Andrade-Navarro, M. A. et al. RNA sequencing of human peripheral blood cells indicates upregulation of immune-related genes in Huntington\u2019s Disease.. Front. Neurol. 11, 573560. https:\/\/doi.org\/10.3389\/fneur.2020.573560 (2020).","journal-title":"Front. Neurol."},{"key":"54412_CR6","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1038\/ejhg.2014.281","volume":"23","author":"A Mastrokolias","year":"2015","unstructured":"Mastrokolias, A. et al. Huntington\u2019s disease biomarker progression profile identified by transcriptome sequencing in peripheral blood. Eur. J. Hum. Genet. 23, 1349\u20131356. https:\/\/doi.org\/10.1038\/ejhg.2014.281 (2015).","journal-title":"Eur. J. Hum. Genet."},{"key":"54412_CR7","doi-asserted-by":"publisher","first-page":"3731","DOI":"10.1172\/JCI64565","volume":"122","author":"A Weiss","year":"2012","unstructured":"Weiss, A. et al. Mutant huntingtin fragmentation in immune cells tracks Huntington\u2019s Disease progression.. J. Clin. Invest. 122, 3731\u20133736. https:\/\/doi.org\/10.1172\/JCI64565 (2012).","journal-title":"J. Clin. Invest."},{"key":"54412_CR8","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1084\/jem.20080178","volume":"205","author":"M Bjorkqvist","year":"2008","unstructured":"Bjorkqvist, M. et al. A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington\u2019s Disease.. J. Exp. Med. 205, 1869\u20131877. https:\/\/doi.org\/10.1084\/jem.20080178 (2008).","journal-title":"J. Exp. Med."},{"key":"54412_CR9","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1021\/pr0700753","volume":"6","author":"A Dalrymple","year":"2007","unstructured":"Dalrymple, A. et al. Proteomic profiling of plasma in Huntington\u2019s Disease reveals neuroinflammatory activation and biomarker candidates. J. Proteome Res. 6, 2833\u20132840. https:\/\/doi.org\/10.1021\/pr0700753 (2007).","journal-title":"J. Proteome Res."},{"key":"54412_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/currents.RRN1231","volume":"3","author":"E Wild","year":"2011","unstructured":"Wild, E. et al. Abnormal peripheral chemokine profile in Huntington\u2019s disease. PLoS. Curr. 3, RRN1231. https:\/\/doi.org\/10.1371\/currents.RRN1231 (2011).","journal-title":"PLoS. Curr."},{"key":"54412_CR11","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.neuron.2020.06.021","volume":"107","author":"H Lee","year":"2020","unstructured":"Lee, H. et al. Cell type-specific transcriptomics reveals that mutant Huntingtin leads to mitochondrial RNA release and neuronal innate immune activation. Neuron 107, 891-908 e898. https:\/\/doi.org\/10.1016\/j.neuron.2020.06.021 (2020).","journal-title":"Neuron"},{"key":"54412_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-020-0880-6","volume":"8","author":"O Al-Dalahmah","year":"2020","unstructured":"Al-Dalahmah, O. et al. Single-nucleus RNA-seq identifies Huntington Disease astrocyte states.. Acta Neuropathol. Commun. 8, 19. https:\/\/doi.org\/10.1186\/s40478-020-0880-6 (2020).","journal-title":"Acta Neuropathol. Commun."},{"key":"54412_CR13","doi-asserted-by":"publisher","first-page":"5534","DOI":"10.1523\/JNEUROSCI.2074-20.2021","volume":"41","author":"S Malaiya","year":"2021","unstructured":"Malaiya, S. et al. Single-nucleus RNA-Seq reveals dysregulation of striatal cell identity due to Huntington\u2019s Disease mutations.. J. Neurosci. 41, 5534\u20135552. https:\/\/doi.org\/10.1523\/JNEUROSCI.2074-20.2021 (2021).","journal-title":"J. Neurosci."},{"key":"54412_CR14","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1016\/j.neuron.2025.05.014","volume":"113","author":"MS Burns","year":"2025","unstructured":"Burns, M. S. et al. Distinct molecular patterns in R6\/2 HD mouse brain: Insights from spatiotemporal transcriptomics. Neuron 113, 2416-2437 e2416. https:\/\/doi.org\/10.1016\/j.neuron.2025.05.014 (2025).","journal-title":"Neuron"},{"key":"54412_CR15","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1093\/hmg\/ddw142","volume":"25","author":"JR Miller","year":"2016","unstructured":"Miller, J. R. et al. RNA-Seq of Huntington\u2019s Disease patient myeloid cells reveals innate transcriptional dysregulation associated with proinflammatory pathway activation.. Hum. Mol. Genet. 25, 2893\u20132904. https:\/\/doi.org\/10.1093\/hmg\/ddw142 (2016).","journal-title":"Hum. Mol. Genet."},{"key":"54412_CR16","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.nbd.2014.10.012","volume":"73","author":"U Trager","year":"2015","unstructured":"Trager, U. et al. Characterisation of immune cell function in fragment and full-length Huntington\u2019s disease mouse models. Neurobiol. Dis 73, 388\u2013398. https:\/\/doi.org\/10.1016\/j.nbd.2014.10.012 (2015).","journal-title":"Neurobiol. Dis"},{"key":"54412_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-28185-4","volume":"8","author":"I Hervas-Corpion","year":"2018","unstructured":"Hervas-Corpion, I. et al. Early alteration of epigenetic-related transcription in Huntington\u2019s disease mouse models. Sci. Rep 8, 9925. https:\/\/doi.org\/10.1038\/s41598-018-28185-4 (2018).","journal-title":"Sci. Rep"},{"key":"54412_CR18","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1093\/hmg\/ddl013","volume":"15","author":"A Hodges","year":"2006","unstructured":"Hodges, A. et al. Regional and cellular gene expression changes in human Huntington\u2019s disease brain. Hum Mol Genet 15, 965\u2013977. https:\/\/doi.org\/10.1093\/hmg\/ddl013 (2006).","journal-title":"Hum Mol Genet"},{"key":"54412_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-024-12771-w","volume":"272","author":"KF van der Zwaan","year":"2025","unstructured":"van der Zwaan, K. F., Feleus, S., Dekkers, O. M., Roos, R. A. C. & de Bot, S. T. Total functioning capacity scale in Huntington\u2019s disease: Natural course over time. J. Neurol 272, 140. https:\/\/doi.org\/10.1007\/s00415-024-12771-w (2025).","journal-title":"J. Neurol"},{"key":"54412_CR20","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","volume":"42","author":"Y Hao","year":"2024","unstructured":"Hao, Y. et al. Dictionary learning for integrative, multimodal and scalable single-cell analysis. Nat. Biotechnol 42, 293\u2013304. https:\/\/doi.org\/10.1038\/s41587-023-01767-y (2024).","journal-title":"Nat. Biotechnol"},{"key":"54412_CR21","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573-3587 e3529. https:\/\/doi.org\/10.1016\/j.cell.2021.04.048 (2021).","journal-title":"Cell"},{"key":"54412_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-018-4772-0","volume":"19","author":"K Street","year":"2018","unstructured":"Street, K. et al. Slingshot: Cell lineage and pseudotime inference for single-cell transcriptomics. BMC Genomics 19, 477. https:\/\/doi.org\/10.1186\/s12864-018-4772-0 (2018).","journal-title":"BMC Genomics"},{"key":"54412_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14766-3","volume":"11","author":"K Van den Berge","year":"2020","unstructured":"Van den Berge, K. et al. Trajectory-based differential expression analysis for single-cell sequencing data. Nat. Commun. 11, 1201. https:\/\/doi.org\/10.1038\/s41467-020-14766-3 (2020).","journal-title":"Nat. Commun."},{"key":"54412_CR24","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/s0092-8674(00)81369-0.","volume":"87","author":"L Mangiarini","year":"1996","unstructured":"Mangiarini, L. et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87, 493\u2013506. https:\/\/doi.org\/10.1016\/s0092-8674(00)81369-0. (1996).","journal-title":"Cell"},{"key":"54412_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-55177-9","volume":"9","author":"A Gallardo-Orihuela","year":"2019","unstructured":"Gallardo-Orihuela, A. et al. Transcriptional correlates of the pathological phenotype in a Huntington\u2019s disease mouse model. Sci. Rep 9, 18696. https:\/\/doi.org\/10.1038\/s41598-019-55177-9 (2019).","journal-title":"Sci. Rep"},{"key":"54412_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-54347-8","volume":"14","author":"F Cano-Cano","year":"2024","unstructured":"Cano-Cano, F. et al. Retinal dysfunction in Huntington\u2019s disease mouse models concurs with local gliosis and microglia activation. Sci. Rep 14, 4176. https:\/\/doi.org\/10.1038\/s41598-024-54347-8 (2024).","journal-title":"Sci. Rep"},{"key":"54412_CR27","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.biocel.2017.07.006.","volume":"90","author":"A Arzalluz-Luque","year":"2017","unstructured":"Arzalluz-Luque, A., Devailly, G., Mantsoki, A. & Joshi, A. Delineating biological and technical variance in single cell expression data. Int. J. Biochem. Cell. Biol 90, 161\u2013166. https:\/\/doi.org\/10.1016\/j.biocel.2017.07.006. (2017).","journal-title":"Int. J. Biochem. Cell. Biol"},{"key":"54412_CR28","doi-asserted-by":"publisher","unstructured":"Kleiveland, C.R. Peripheral Blood Mononuclear Cells. 2015, 161\u2013167, NBK500157 [bookaccession]https:\/\/doi.org\/10.1007\/978-3-319-16104-4_15.","DOI":"10.1007\/978-3-319-16104-4_15"},{"key":"54412_CR29","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/ana.25973","volume":"89","author":"DJS Kuipers","year":"2021","unstructured":"Kuipers, D. J. S. et al. EIF2AK2 missense variants associated with early onset generalized dystonia. Ann. Neurol. 89, 485\u2013497. https:\/\/doi.org\/10.1002\/ana.25973 (2021).","journal-title":"Ann. Neurol."},{"key":"54412_CR30","doi-asserted-by":"publisher","first-page":"11023","DOI":"10.1073\/pnas.0504921102","volume":"102","author":"F Borovecki","year":"2005","unstructured":"Borovecki, F. et al. Genome-wide expression profiling of human blood reveals biomarkers for Huntington\u2019s disease. Proc. Natl. Acad. Sci. U.S.A. 102, 11023\u201311028. https:\/\/doi.org\/10.1073\/pnas.0504921102 (2005).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"54412_CR31","doi-asserted-by":"publisher","first-page":"14424","DOI":"10.1073\/pnas.0703652104","volume":"104","author":"H Runne","year":"2007","unstructured":"Runne, H. et al. Analysis of potential transcriptomic biomarkers for Huntington\u2019s disease in peripheral blood. Proc. Natl. Acad. Sci. U.S.A. 104, 14424\u201314429. https:\/\/doi.org\/10.1073\/pnas.0703652104 (2007).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"54412_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/srep44849","volume":"7","author":"DJ Hensman Moss","year":"2017","unstructured":"Hensman Moss, D. J. et al. Huntington\u2019s disease blood and brain show a common gene expression pattern and share an immune signature with Alzheimer\u2019s disease. Sci. Rep. 7, 44849. https:\/\/doi.org\/10.1038\/srep44849 (2017).","journal-title":"Sci. Rep."},{"key":"54412_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0046492","volume":"7","author":"KH Chang","year":"2012","unstructured":"Chang, K. H., Chen, Y. C., Wu, Y. R., Lee, W. F. & Chen, C. M. Downregulation of genes involved in metabolism and oxidative stress in the peripheral leukocytes of Huntington\u2019s disease patients. PLoS ONE 7, e46492. https:\/\/doi.org\/10.1371\/journal.pone.0046492 (2012).","journal-title":"PLoS ONE"},{"key":"54412_CR34","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.adi8753","volume":"17","author":"T Rosenlehner","year":"2024","unstructured":"Rosenlehner, T. et al. Reciprocal regulation of mTORC1 signaling and ribosomal biosynthesis determines cell cycle progression in activated T cells. Sci. Signal. 17, eadi8753. https:\/\/doi.org\/10.1126\/scisignal.adi8753 (2024).","journal-title":"Sci. Signal."},{"key":"54412_CR35","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2416722121","volume":"121","author":"S Gottlieb","year":"2024","unstructured":"Gottlieb, S. et al. AMBRA1 controls the translation of immune-specific genes in T lymphocytes. Proc. Natl. Acad. Sci. U. S. A. 121, e2416722121. https:\/\/doi.org\/10.1073\/pnas.2416722121 (2024).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"54412_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1411957","volume":"15","author":"A Gomez-Moron","year":"2024","unstructured":"Gomez-Moron, A. et al. Cytosolic protein translation regulates cell asymmetry and function in early TCR activation of human CD8(+) T lymphocytes. Front. Immunol. 15, 1411957. https:\/\/doi.org\/10.3389\/fimmu.2024.1411957 (2024).","journal-title":"Front. Immunol."},{"key":"54412_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0183264","volume":"12","author":"LM Valor","year":"2017","unstructured":"Valor, L. M., Rodriguez-Bayona, B., Ramos-Amaya, A. B., Brieva, J. A. & Campos-Caro, A. The transcriptional profiling of human in vivo-generated plasma cells identifies selective imbalances in monoclonal gammopathies. PLoS ONE 12, e0183264. https:\/\/doi.org\/10.1371\/journal.pone.0183264 (2017).","journal-title":"PLoS ONE"},{"key":"54412_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21637-y","volume":"12","author":"M Eshraghi","year":"2021","unstructured":"Eshraghi, M. et al. Mutant Huntingtin stalls ribosomes and represses protein synthesis in a cellular model of Huntington disease. Nat. Commun. 12, 1461. https:\/\/doi.org\/10.1038\/s41467-021-21637-y (2021).","journal-title":"Nat. Commun."},{"key":"54412_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2024.106488","volume":"195","author":"E Martin-Solana","year":"2024","unstructured":"Martin-Solana, E. et al. Progressive alterations in polysomal architecture and activation of ribosome stalling relief factors in a mouse model of Huntington\u2019s disease. Neurobiol. Dis. 195, 106488. https:\/\/doi.org\/10.1016\/j.nbd.2024.106488 (2024).","journal-title":"Neurobiol. Dis."},{"key":"54412_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.176755","volume":"978","author":"R Sood","year":"2024","unstructured":"Sood, R., Anoopkumar-Dukie, S., Rudrawar, S. & Hall, S. Neuromodulatory effects of leukotriene receptor antagonists: A comprehensive review. Eur. J. Pharmacol. 978, 176755. https:\/\/doi.org\/10.1016\/j.ejphar.2024.176755 (2024).","journal-title":"Eur. J. Pharmacol."},{"key":"54412_CR41","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1038\/s41556-024-01414-x","volume":"26","author":"R Aviner","year":"2024","unstructured":"Aviner, R. et al. Polyglutamine-mediated ribotoxicity disrupts proteostasis and stress responses in Huntington\u2019s disease. Nat. Cell Biol. 26, 892\u2013902. https:\/\/doi.org\/10.1038\/s41556-024-01414-x (2024).","journal-title":"Nat. Cell Biol."},{"key":"54412_CR42","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.1093\/brain\/awz230","volume":"142","author":"J Creus-Muncunill","year":"2019","unstructured":"Creus-Muncunill, J. et al. Increased translation as a novel pathogenic mechanism in Huntington\u2019s disease. Brain 142, 3158\u20133175. https:\/\/doi.org\/10.1093\/brain\/awz230 (2019).","journal-title":"Brain"},{"key":"54412_CR43","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.drudis.2018.09.008","volume":"24","author":"J Michael","year":"2019","unstructured":"Michael, J., Marschallinger, J. & Aigner, L. The leukotriene signaling pathway: A druggable target in Alzheimer\u2019s disease. Drug Discov. Today 24, 505\u2013516. https:\/\/doi.org\/10.1016\/j.drudis.2018.09.008 (2019).","journal-title":"Drug Discov. Today"},{"key":"54412_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02714-z","volume":"20","author":"M Tassan Mazzocco","year":"2023","unstructured":"Tassan Mazzocco, M. et al. Exploring the neuroprotective effects of montelukast on brain inflammation and metabolism in a rat model of quinolinic acid-induced striatal neurotoxicity. J. Neuroinflammation 20, 34. https:\/\/doi.org\/10.1186\/s12974-023-02714-z (2023).","journal-title":"J. Neuroinflammation"},{"key":"54412_CR45","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.neuroscience.2010.08.039","volume":"171","author":"H Kalonia","year":"2010","unstructured":"Kalonia, H., Kumar, P., Kumar, A. & Nehru, B. Protective effect of montelukast against quinolinic acid\/malonic acid induced neurotoxicity: Possible behavioral, biochemical, mitochondrial and tumor necrosis factor-alpha level alterations in rats. Neuroscience 171, 284\u2013299. https:\/\/doi.org\/10.1016\/j.neuroscience.2010.08.039 (2010).","journal-title":"Neuroscience"},{"key":"54412_CR46","doi-asserted-by":"publisher","first-page":"4737","DOI":"10.1172\/JCI64484","volume":"122","author":"W Kwan","year":"2012","unstructured":"Kwan, W. et al. Mutant huntingtin impairs immune cell migration in Huntington disease. J. Clin. Invest. 122, 4737\u20134747. https:\/\/doi.org\/10.1172\/JCI64484 (2012).","journal-title":"J. Clin. Invest."},{"key":"54412_CR47","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcaa172","volume":"2","author":"CT Mitchell","year":"2020","unstructured":"Mitchell, C. T. et al. Longitudinal expression changes are weak correlates of disease progression in Huntington\u2019s disease. Brain Commun. 2, fcaa172. https:\/\/doi.org\/10.1093\/braincomms\/fcaa172 (2020).","journal-title":"Brain Commun."},{"key":"54412_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21228474","author":"GD Colpo","year":"2020","unstructured":"Colpo, G. D., Rocha, N. P., Furr Stimming, E. & Teixeira, A. L. Gene expression profiling in Huntington\u2019s disease: Does comorbidity with depressive symptoms matter?. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms21228474 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"54412_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1190841","volume":"14","author":"F Qing","year":"2023","unstructured":"Qing, F. & Liu, Z. Interferon regulatory factor 7 in inflammation, cancer and infection. Front. Immunol. 14, 1190841. https:\/\/doi.org\/10.3389\/fimmu.2023.1190841 (2023).","journal-title":"Front. Immunol."},{"key":"54412_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1236923","volume":"14","author":"W Ma","year":"2023","unstructured":"Ma, W., Huang, G., Wang, Z., Wang, L. & Gao, Q. IRF7: Role and regulation in immunity and autoimmunity. Front. Immunol. 14, 1236923. https:\/\/doi.org\/10.3389\/fimmu.2023.1236923 (2023).","journal-title":"Front. Immunol."},{"key":"54412_CR51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0143563","volume":"10","author":"A Labadorf","year":"2015","unstructured":"Labadorf, A. et al. RNA sequence analysis of human Huntington disease brain reveals an extensive increase in inflammatory and developmental gene expression. PLoS ONE 10, e0143563. https:\/\/doi.org\/10.1371\/journal.pone.0143563 (2015).","journal-title":"PLoS ONE"},{"key":"54412_CR52","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1093\/jnen\/60.2.161","volume":"60","author":"E Sapp","year":"2001","unstructured":"Sapp, E. et al. Early and progressive accumulation of reactive microglia in the Huntington disease brain. J. Neuropathol. Exp. Neurol. 60, 161\u2013172. https:\/\/doi.org\/10.1093\/jnen\/60.2.161 (2001).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"54412_CR53","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow, S. A. et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541, 481\u2013487. https:\/\/doi.org\/10.1038\/nature21029 (2017).","journal-title":"Nature"},{"key":"54412_CR54","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1038\/s41591-023-02566-3","volume":"29","author":"DK Wilton","year":"2023","unstructured":"Wilton, D. K. et al. Microglia and complement mediate early corticostriatal synapse loss and cognitive dysfunction in Huntington\u2019s disease. Nat. Med. 29, 2866\u20132884. https:\/\/doi.org\/10.1038\/s41591-023-02566-3 (2023).","journal-title":"Nat. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54412-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54412-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54412-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:04:53Z","timestamp":1785848693000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54412-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["54412"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-54412-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.64898\/2025.12.14.694089","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]},"assertion":[{"value":"2 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"23980"}}